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Previewsseparate elements like cuirass, breast-
plate, brassard, and helmet. The connec-
tions between these elements might be
more vulnerable to a sword of therapy
than originally thought.
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It once seemed clear that negative selection of self-specific T cells in the thymuswas themajormechanism of
central tolerance. But recent studies, including Legoux et al. (2015) in this issue of Immunity, show that this is
not always the case.It’s hard to think of a subject over which
more ink has been spilled in immunology
than the dilemma of how organisms
fortunate enough to have an adaptive
immune system distinguish self from
non-self. This has been debated almost
since the field began, when Ehrlich
mused over how antisera, with their
diverse specificities, could somehow
avoid what he called ‘‘horror autotoxis,’’
or self reactivity (Silverstein, 2001). Fast
forward to the 1950s, and with the clonal
selection theory, Burnet proposed that
self-specific lymphocytes were disposed
of, or clonally deleted (Burnet, 1957). De-
cades later, Nossal found evidence that
specific B cells could also be inacti-
vated, at least in vitro, which he referred
to as ‘‘clonal anergy’’ (Nossal and Pike,
1980). So there seemed to be at least
two competing models for how organ-
isms dealt with self-specific lympho-
cytes: either during their maturation,
also known as central tolerance, or in
the periphery, known as peripheral toler-
ance. In the T cell world, clonal deletion
became known as ‘‘negative selection,’’to distinguish it from ‘‘positive selec-
tion,’’ which is the process by which
T cells are selected to be able to recog-
nize peptide antigens in the context of
one’s own major histocompatibility com-
plex (MHC) molecules. Late in the 1980s,
a series of dramatic papers, based on
either endogenous superantigen effects
or T cell receptor transgenic mice,
showed the wholesale deletion of self-
specific T cells in the thymus, basically
expunging any thoughts of anergy being
a viable option for central tolerance
(Goodnow and Ohashi, 2013). Interest-
ingly, at the same time, Goodnow and
colleagues showed equally dramatic ev-
idence of clonal anergy in an immunolo-
globulin transgenic system (Goodnow
et al., 1989), but this didn’t seem to
have any influence on the T cell commu-
nity. Instead, the issue seemed to be
settled that, at least with respect to
thymocyte maturation, it was all about
negative selection getting rid of all, or
almost all, of the ‘‘dangerous’’ T cells.
But even then, cracks began appearing
in that certainty. First, it was demon-strated that self antigens, at least in
mouse models, could trigger autoimmu-
nity, but most thought these were the
exception rather than the rule. Another
warning sign emerged when Jensen
et al. showed that, whereas work with
TCR transgenics had showed that gd
T cells specific for a minor histocompat-
ibility gene were negatively selected in
the presence of that molecule in vivo,
analysis using a tetramer reagent in
wild-type mice found no evidence of
negative selection (Jensen et al., 2008).
Although there had been hints of trans-
genic artifacts before, this was the first
indication that things could go seriously
wrong in terms of the earlier interpreta-
tion. More recently, my own group, as
well as others, has found that self-spe-
cific T cells are quite abundant in the pe-
riphery of healthy individuals, human or
mouse, although when self versus non-
self can be compared directly with the
same tetrameric reagents, as in the
case of the male antigen H-Y (or,
SmcY), there is, at least in the human
case, a significant (33) reduction in theovember 17, 2015 ª2015 Elsevier Inc. 833
Figure 1. Distinct Zones of T Cell Tolerance
Generalizing from the results of Legoux et al.
and others, there appear to be at least three
distinct zones where T cell tolerance to antigens
expressed in those areas manifests itself in
different ways. Central tolerance, which involves
thymocytes encountering peptides derived from
self molecules in the thymus, seems to deal
with self-specific ab T cells by either inducing cell
death or negative selection or by a type of
anergy, where T cells emerge in the periphery with
a higher threshold for activation. In the second
zone, illustrated by the lung and intestinal data,
there is no apparent negative selection, but Treg
cell numbers are elevated, and these cells seem to
be the main enforcers of tolerance. In the third
zone, none of these three mechanisms seems to
be operative, and thus are seemingly immunolog-
ically ignorant.
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ficity in males in comparison to females
(Su et al., 2013; Yu et al., 2015). In
addition, compared to foreign antigen-
specific T cells, a collection of self-anti-
gen-specific T cells were refractory to
antigen-dependent stimulation, although
both could be stimulated by anti-CD3
plus anti-CD28 (Yu et al., 2015).
In this issue of Immunity, Legoux et al.
(2015) enter the fray, taking a very clever
tack and asking whether tissue-specific
expression has an impact on negative
selection. By taking advantage of the
many available transgenics expressing
cre in specific tissues for the purposes
of making conditional knockouts, they834 Immunity 43, November 17, 2015 ª2015looked for and found a dominant class II
MHC (I-Ab) T cell epitope in the cre pro-
tein and then assayed the fraction of
T cells specific for cre by using a tetramer
reagent in the various cre-expressing
transgenes. In the case of a ubiquitously
expressing cre construct, they found a
significant degree of deletion, approxi-
mately 60% in both the thymus and
periphery, very similar to recent work
analyzing the Y-chromosome-encoded
SmcY antigen in males versus in females,
and not at all like the super-efficient
deletion of roughly 99% of specific
T cells in the transgenic systems previ-
ously. Even more remarkably, when
they examined mice expressing cre in
a tissue-specific context—lung, intes-
tine, and pancreas—they could find no
evidence of negative selection at all.
They also investigated whether there
was a role for cre-specific regulatory T
(Treg) cells and found that in the intesti-
nal- and lung-specific cre mice, but
not in the ubiquitously expressed and
pancreas-specific cre mice, there was
an elevation of Treg-cell-phenotype
CD4+ T cells that were stained with the
cre:I-Ab tetramer. In the lung and intesti-
nal cases, the authors noted an inhibition
of cre-specific T cell responses. To
determine whether Treg cells were
responsible for this inhibition, they em-
ployed an elegant tetracycline inducible
method to selectively kill Treg cells, and
when they did this, T cell reactivity was
largely restored in those cre mice. Le-
goux et al. suggest that this type of
Treg cell control is not important in the
case of pancreas expression of antigens
because this organ is not part of the front
line of immune defense, unlike the lungs
and intestine, which are constantly hav-
ing to distinguish self from dangerous
foreign entities. This role of Treg cells
is consistent with the previous results
of Sakaguchi (Maeda et al., 2014),
who found that T cells specific for
MART-1, a melanocyte-specific antigen,
are present in the peripheral blood of
healthy human beings but held in check
by Treg cells.
There is also an important contrast be-
tween the ubiquitously expressed cre
mice and those dependent on Treg cell
control of tolerance, in that the former
seems to be an intrinsic form of cell auton-
omous anergy, whereas repeated immu-
nization with cre plus adjuvant of theElsevier Inc.lung and intestinal cre-expressing mice
can produce a response, indicating that
this form of tolerance is somewhat shaky.
The authors suggest that this vulnerability
to the breaking of tolerance to tissue-spe-
cific antigens could be why autoimmunity
typically appears as a tissue-specific dis-
ease. Legoux et al. also point out that this
suggests that effective therapeutic vac-
cines against tumor antigens in cancer is
at least of possible benefit, as it has
been in some cases, although these vac-
cines have generally been too rarely suc-
cessful to be a stand-alone treatment.
Although these results involve only one
antigen, and thus their generality needs to
be confirmed with other examples, the re-
sults regarding central tolerance do corre-
spond well with other reports (Yu et al.,
2015, Su et al., 2013). But assuming there
is corroboration with other antigens for
the peripheral tolerance results, this pa-
per sheds important new light on the vari-
ety of tolerance mechanisms in play with
respect to T cells. This is illustrated in
Figure 1, where there are at least three
distinct immunological environments
for T cell tolerance. The first is a central
tolerance zone—the thymus in the case
of T cells, where T cells mature and
encounter many, but not all, potential an-
tigens in the context of their own MHC
repertoire. This is facilitated by the Aire
protein, which seems engaged in ex-
pressing a large number of proteins for
the purpose of being presented to
maturing thymocytes (as reviewed by
Goodnow and Ohashi, 2013). The conse-
quences of self recognition in this central
zone are either the induction of apoptotic
death e.g., negative selection, or a type of
anergy, which makes those T cells more
difficult to stimulate in the periphery. A
second tolerance zone is postulated by
Legoux et al. to be the extensive mucosal
immune compartments of the lung and
intestine where many immunologically
significant encounters take place with mi-
crobes. In this zone, they see no evidence
for negative selection for the cre protein,
but instead see a heightened number of
Treg cells and a direct role for those cells
in suppressing responses. It would inter-
esting to know whether this is also true
for lymphocytes in the skin, another tissue
that has extensive contact with microbes,
but is not mucosal. A third distinct
environment is represented by the results
for pancreatic expression, where there
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Previewsseems to be no consequences for cre-
specific T cells expression there. This
seems to be a state of immunological
ignorance, and a puzzle as to just
how one protects against autoimmunity
in such cases. Perhaps the answer is
that there is yet another, unknown mech-
anism promoting tolerance in organs of
this type.
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How inflammatory caspases trigger pyroptotic cell death is mostly unexplained. In this issue of Immunity,
Nu´n˜ez and colleagues report that caspase-11 cleaves the transmembrane channel pannexin-1, causing an
efflux of cellular ATP that promotes a P2X7 receptor-dependent pyroptosis.The term pyroptosis was coined to
describe a proinflammatory form of cell
death (Bergsbaken et al., 2009). It is
derived from the Greek roots pyro, mean-
ing fire, and ptosis, which denotes falling
and matches the terms used for other
forms of programmed cell death. MLKL
pseudokinase phosphorylation or loss of
mitochondrial integrity, which are hall-
marks of necrotic or apoptotic cell death
respectively, are not required for pyropto-
sis. Instead, this pathway is defined by
the activation of inflammatory caspases,
cell swelling, and rapid destabilization
of plasmamembrane integrity. This results
in the release of cellular content including
danger-associated molecular patterns
(DAMPs) and cytokines that mount a
robust inflammatory response. Pyroptosis
can also contribute to the clearance
of intracellular bacteria; by disrupting
infected cells it can release pathogens,
making them susceptible to phagocy-
tosis, andkillingbyneutrophils (Jorgensen
and Miao, 2015).
Initiation of pyroptosis requires at
least one member of the inflammatorycaspases, a family of proteases including
caspase-1 and caspase-11 in mice and
caspase-1, caspase-4, and caspase-5 in
humans. These enzymes resemble the
initiator caspases involved in apoptosis
but are unable to process the many sub-
strates associated with initiation and
execution of apoptotic cell death; in fact,
only a few inflammatory caspases sub-
strates have been described so far.
Inflammatory caspases are activated
within high molecular weight complexes
known as inflammasomes. Caspase-1 in-
flammasomes typically assemble upon
oligomerization of a scaffold protein that
directly or indirectly senses activating
stress signals or pathogen signatures.
Beyond their role in promoting pyroptosis,
caspase-1 inflammasomesarewell known
for their involvement in the maturation of
the pro-inflammatory cytokines IL-1b and
IL-18, an activity that cannot be fulfilled
directly by caspase-11. The caspase-11
inflammasome, also known as the non-
canonical inflammasome, is formed upon
cytosolic exposure of lipopolysaccharide
(LPS), a bacterial component that bindsand directly activates mouse caspase-
11, as well as the two human paralogues
caspase-4 and caspase-5. Activation of
the caspase-11 inflammasome has been
described as the main pathway involved
in LPS-induced lethality in mice, suggest-
ing that pyroptosis might contribute to in-
flammatory syndromes in vivo.
Because the proteolytic activity of
the inflammatory caspases is required
to initiate pyroptosis, it is likely that the
cleavage of at least one of their substrate
promotes cell death. Yet, little is known on
the proteolytic activities that might initiate
the cascade of events associated with
pyroptotic cell death.
A study in this issue of Immunity (Yang
et al., 2015) sheds new light on the
initial steps of pyroptosis. The groups of
Gabriel Nu´n˜ez and Quin Liu describe the
cleavage of pannexin-1 as a pyroptosis-
initiating event.
Pannexin-1 is a plasma membrane
channel widely expressed in diverse tis-
sues. It forms pore channels that
allow the passage of small molecules
such as ions and nucleotides betweenovember 17, 2015 ª2015 Elsevier Inc. 835
